newsfilter
← Latest News
GlobeNewswire·

miRagen Regains Compliance With Nasdaq Listing Requirements

BOULDER, Colo., July 02, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted...